Ur Advanced Therapeutics Private Limited, a active private limited company, was established on 17 July 2020 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100TG2020PTC141847. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹1.30 Cr.
It upholds a compliant status. Its leadership includes Sai Pooja Anne (Director), Aparna Rachamallu (Director), Jangamreddy Jagan Mohan Reddy (Director). Past directors included Sai Pooja Anne, Kummetha Raghunathareddy, Adinarayana Reddy Yerrapureddy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Villa No.19, Sark-2, Mokila,, Hyderabad, Telangana, 501203.
U73100TG2020PTC141847
141847
17 July 2020
₹12.00 Cr
₹1.30 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ur Advanced Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sai Pooja Anne | Director | 16 Dec 2023 | Current |
| Aparna Rachamallu | Director | 16 Mar 2023 | Current |
| Jangamreddy Jagan Mohan Reddy | Director | 17 Jul 2020 | Current |
| Bhanu Prasad Kommineni | Director | 16 Dec 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 06 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ur Advanced Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 314.23% increase. The company also saw a substantial improvement in profitability, with a 37.37% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Ur Advanced Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ur Advanced Therapeutics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ur Advanced Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ur Advanced Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ur Advanced Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Ur Advanced Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Sai Pooja Anne was appointed as a Director was appointed as a Director on 16 Dec 2023 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
The activity Bhanu Prasad Kommineni was appointed as a Director was appointed as a Director on 16 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
The activity Aparna Rachamallu was appointed as a Director was appointed as a Director on 16 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
Jangamreddy Jagan Mohan Reddy was appointed as a Director was appointed as a Director on 17 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
The CIN of Ur Advanced Therapeutics Private Limited is U73100TG2020PTC141847.
Ur Advanced Therapeutics Private Limited is headquartered at Villa No.19, Sark-2, Mokila,, Hyderabad, Telangana, 501203.
Ur Advanced Therapeutics Private Limited was incorporated on 17 July 2020.
The current directors of Ur Advanced Therapeutics Private Limited are
The primary industry of Ur Advanced Therapeutics Private Limited is Professional, Scientific And Technical.
Ur Advanced Therapeutics Private Limited is unlisted.
The authorized capital of Ur Advanced Therapeutics Private Limited is ₹12.00 Cr, and the paid-up capital is ₹1.30 Cr.
The compliance status of Ur Advanced Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX